MaxCyte shares rise amid double-digit revenue increase marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
MaxCyte Inc on Tuesday said that promising returns from its strategic platform licence program had bolstered its quarterly revenue expectations.
MaxCyte is a Maryland, US-based provider of cell.
MaxCyte teams with Singapore-based Lion to support TCR-T cell work | Finance News shareprices.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shareprices.com Daily Mail and Mail on Sunday newspapers.
MaxCyte Inc on Wednesday said it had signed a strategic platform licence with Lion TCR to promote the latter s T cell receptor-T cell pipeline.
MaxCyte is a Maryland, US-based provider of cell.
MaxCyte Inc on Thursday said it expects revenue in the third quarter and for all of 2023 to fall from a year before, citing volatility in customer activity in the life science tools sector.
MaxCyte.